Management of pyrazinamide toxicity primarily involves discontinuation of the drug and supportive care. In cases of hepatotoxicity, cessation of all hepatotoxic medications may be necessary. For hyperuricemia, patients may require treatment with allopurinol or other urate-lowering therapies.
